Compare RANI & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | ALOT |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 109.5M |
| IPO Year | 2021 | 1995 |
| Metric | RANI | ALOT |
|---|---|---|
| Price | $0.95 | $15.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 42.7K |
| Earning Date | 05-07-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.14 | ★ 83.94 |
| EPS | ★ N/A | N/A |
| Revenue | $1,633,000.00 | ★ $150,515,000.00 |
| Revenue This Year | $274.77 | N/A |
| Revenue Next Year | $79.44 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.39 | $6.96 |
| 52 Week High | $3.87 | $15.69 |
| Indicator | RANI | ALOT |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 76.37 |
| Support Level | $0.86 | $8.77 |
| Resistance Level | $1.10 | N/A |
| Average True Range (ATR) | 0.09 | 0.50 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 28.23 | 86.35 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Aerospace. It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.